Question Bank › Buying its own future output

Buying its own future output

Buying its own future output: the company is spending now to own more of the value it already helps create

Calls Tested
490
Answered YES
22
Hit Rate
4.5%
rare by design

Adaptive Biotechnologies Corporation (ADPT) — this company's answers

NO on the Q4 2022 call 2023-02-14 C+
The model's full reasoning — Q4 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司正在沿着价值链向上或向下移动,即承担或直接控制以前由他人执行的步骤,并且这一举措已经在执行中,已经改变了公司的收入或能力,而不是计划或考虑中的。 在记录中,管理层讨论了多个方面,包括MRD业务、免疫医学、药物发现等。但我们需要寻找的是关于公司内部化某个价值链环节的具体描述,例如将以前外包的步骤内部化,或直接向最终用户销售等。 在记录中,管理层提到了“Epic integration”(电子病历集成),这可能是将订单流程内部化,但这是否是“价值链”的移动?Epic集成是让医生通过电子病历系统直接下单,这可能是销售渠道的改进,但并非接管以前由第三方执行的步骤。此外,管理层提到了“clonoSEQ”测试,但这是公司自己的产品,没有提到将以前外包的制造或服务内部化。 在药物发现方面,管理层提到了与Genentech的合作,但这是合作伙伴关系,不是内部化。管理层还提到了内部自身免疫项目,但这是研发,不是价值链移动。 关于“T-Detect”,管理层提到决定延迟商业化,但这不是内部化。 因此,没有明确描述公司正在将以前由他人执行的步骤内部化,并且已经执行。管理层讨论的是增长、扩张、销售团队增加等,但这些都是现有业务内的增长,不是价值链移动。 所以答案应为NO。

← Back to the full ADPT analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe that the company is CURRENTLY MOVING ITSELF FURTHER UP OR DOWN ITS OWN VALUE CHAIN — taking ownership or direct control of a step in the chain that someone else used to perform, own, or capture the margin on — and does management convey that this move is ALREADY BEING EXECUTED and is already changing what the company earns or can do, rather than being planned or contemplated? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent phenomenon: the company is claiming a link in the chain it previously depended on others for, so that value that used to leak out to a supplier, intermediary, partner, contractor, or customer now stays inside the company. Any genuine expression of this counts, and the form varies widely across industries. For example — bringing manufacturing, assembly, fabrication, or a key process in-house that was previously outsourced; producing, mining, refining, growing, or securing its own inputs, materials, components, or supply instead of buying them; taking over installation, service, maintenance, logistics, delivery, or support work that contractors or third parties used to perform; selling directly to end users, patients, or consumers where it previously sold only through distributors, wholesalers, retailers, agents, or intermediaries; opening or acquiring its own outlets, clinics, branches, or channels rather than relying on others' shelf space or referral flow; taking over a customer's or partner's step in the process and getting paid for the whole job rather than a piece of it; buying out a licensee, franchisee, joint-venture partner, or distributor and running that activity itself; internalizing a capability — testing, design, engineering, software, data, financing, underwriting — that it previously paid outsiders for; or otherwise capturing a portion of the end price that another party used to keep. Three things should come through in management's own voice. First, THE MOVE IS REAL AND IN MOTION NOW — the facility is running or being commissioned, the direct channel is live and selling, the in-house team is doing the work, the buyout has closed, the first units are being produced internally — not a strategy under evaluation, a letter of intent, or an intention for a future year. Second, MANAGEMENT EXPLAINS WHY IT IS WORTH MORE INSIDE — for example that the company now keeps margin it previously paid away, controls quality, cost, supply, or timing it previously could not, reaches customers it could not reach through the old chain, can move faster or serve business the old arrangement made uneconomic, or is no longer at the mercy of a counterparty that constrained it. Third, THE PAYOFF IS MOSTLY STILL AHEAD — management conveys, directly or plainly in substance, that this integration is early relative to what it will contribute: the internalized step is only partly ramped, only some volume or some geographies have converted, or the reported results still largely reflect the old chain, so today's numbers understate the company as it is being reconfigured. Management may be candid about the cost, disruption, or learning curve of doing this; that strengthens rather than weakens a YES. Answer NO if the company is simply growing, expanding capacity, or investing within its existing role in the chain, with no step being taken over from another party. NO if the move is only announced, being studied, contemplated, negotiated, or contingent on financing, approvals, or decisions not yet obtained. NO if what is described is an ordinary acquisition of a similar business at the same level of the chain — buying a competitor, adding scale, or entering a new geography doing the same thing — rather than absorbing a different step. NO if the company is going the other direction — outsourcing, divesting operations, handing work to partners, exiting direct channels, or becoming more dependent on intermediaries. NO if the integration is forced or defensive, undertaken because a supplier failed, a distributor dropped the company, a partner walked away, or capacity vanished, rather than chosen to capture value. NO if the internalization is trivial relative to the company or is routine housekeeping every business in the industry does. NO if the move is essentially complete and already fully reflected in results, with nothing meaningful still to convert. NO if the only relevant language is generic — "vertical integration," "controlling our own destiny," "owning the customer relationship," "end-to-end solutions" — without concrete description of what step the company is actually now performing that it did not before. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
PFE Pfizer Inc. Q4 2023 2024-01-30 F
BZUN Baozun Inc. Q2 2023 2023-08-28 D
KMDA Kamada Ltd. Q2 2023 2023-08-16 B+
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
HROW Harrow Health, Inc. Q4 2021 2022-03-10 C
SLQT SelectQuote, Inc. Q2 2022 2022-02-07 F
LC LendingClub Corporation Q4 2021 2022-01-26 A
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
KNDI Kandi Technologies Group, Inc. Q2 2021 2021-08-09 F
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
PRPO Precipio, Inc. Q3 2018 2018-11-19 D
T AT&T Inc. Q3 2018 2018-10-24 C+
KOP Koppers Holdings Inc. Q2 2018 2018-08-12 C+
XOM Exxon Mobil Corporation Q2 2018 2018-07-27 C
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
FLEX Flex Ltd. Q1 2018 2017-07-28 F
DAN Dana Incorporated Q1 2017 2017-05-02 B
GES Guess?, Inc. Q1 2017 2016-05-25 F

How the model reasoned

FLEX · Q1 2018 → YESThe question is about whether Flex Ltd is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows Flex is actively internalizing a previously external step in the shoe manufacturing value chain by taking ownership of automation, process redesign, and end-to-end production for Nike. Management describes this as an ongoing, real-time execution: “we’re vertically integrating technologies,” “rethinking all of the whole supply process we’re applying automation technologies,” “we’ve manufactured over 1 million pairs,” and “we took over the facility in September” for Bose, with the Nike factory transition “complete by October.” They explain the value capture: the company now keeps margin it previously paid away, controls quality, cost, supply, and timing previously constrained by a counterparty, and serves customers it could not reach through the old chain. While acknowledging the ramp is early (losses persist through Q2, breakeven expected by year-end), the move is already changing what Flex earns and can do, not merely planned or contemplated. This meets all three required elements.
XOM · Q2 2018 → YESThe question is about whether ExxonMobil is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows ExxonMobil actively internalizing logistics and supply-chain steps that previously required external partners or intermediaries. Neil Chapman explicitly states they “will get engaged in the connectivity between the Permian and our Gulf Coast refining and chemical assets,” with equity participation in logistics, the Wink terminal acquisition (closed late 2017), 11 active completion crews, and a signed letter of intent for a 1 million bpd long-haul crude pipeline. These moves are already producing results: Gulf Coast refineries are “already processing our production levels and more, capturing the benefits of disadvantaged feed cost.
KMDA · Q2 2023 → YESThe question is about whether management describes the company currently moving itself further up or down its own value chain, taking ownership of a step that someone else used to perform, and that th...YES The transcript shows management describing the 2021 acquisition of the Beaumont plasma collection center as the company's entry into U.S. plasma collection, with the explicit goal of becoming a "fully integrated specialty plasma product company." They state they are "successfully expanding" capacity at the first center (already acquired and operational) and plan to open the second in Houston in early 2024. This is presented as an active, ongoing move to internalize plasma collection that previously depended on external suppliers.

More from the question bank

Customers eating the frictionDeliberately different by designNumbers reset the ceilingOperating without a netWorking harder than they are being paid forMid-ramp quarter: contribution has started bAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.